Abstract
Mesenchymal stem cells (MSCs) have great capacity for proliferation, self-renewal and differentiation into different, more specialized cell lines. This population of adult stem cells is easily obtained and, due to their immunomodulatory and antimicrobial characteristics, they have been strong candidates as a new therapeutic tool to treat sepsis. In this context, preliminary studies in our…